Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial.
